Literature DB >> 19531877

Working memory training in patients with multiple sclerosis - comparison of two different training schedules.

Annamarie Vogt1, Ludwig Kappos, Pasquale Calabrese, Markus Stöcklin, Leo Gschwind, Klaus Opwis, Iris-Katharina Penner.   

Abstract

PURPOSE: Evaluation of two different training schedules of a computer based working memory training (BrainStim) in patients with multiple sclerosis (MS).
METHOD: Forty-five MS outpatients were allocated to two different training groups and a control group without training. Patients with treatment received 16 training sessions scheduled either as a high intensity training (4 times per week for 4 weeks) or as a distributed training (2 times per week for 8 weeks). A neuropsychological test battery including self-report measures was applied at baseline and at retest. The baseline assessment was performed twice at an interval of two weeks to control for possible learning effects.
RESULTS: In the outcome measures training for both intervention groups led to significantly improved fatigue symptoms as well as working memory -, and mental speed performances. Log files recorded during training showed a similar increase in levels of difficulty for both intervention groups as training progressed. No effects were found on short term memory, quality of life or depression.
CONCLUSIONS: Since comparable improvements were observed in both training groups, BrainStim can be applied as a therapeutic intervention adjusted to the personal agenda of MS patients.

Entities:  

Mesh:

Year:  2009        PMID: 19531877     DOI: 10.3233/RNN-2009-0473

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  30 in total

Review 1.  Does working memory training work? The promise and challenges of enhancing cognition by training working memory.

Authors:  Alexandra B Morrison; Jason M Chein
Journal:  Psychon Bull Rev       Date:  2011-02

2.  Home-Based Computer-Assisted Cognitive Training: Feasibility and Perceptions of People with Multiple Sclerosis.

Authors:  Alexa Stuifbergen; Heather Becker; Stephanie Morgan; Janet Morrison; Frank Perez
Journal:  Int J MS Care       Date:  2011-01-01

Review 3.  Non Pharmacological Cognitive Enhancers - Current Perspectives.

Authors:  Ankur Sachdeva; Kuldip Kumar; Kuljeet Singh Anand
Journal:  J Clin Diagn Res       Date:  2015-07-01

4.  A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial.

Authors:  M Huiskamp; E Dobryakova; G D Wylie; J DeLuca; N D Chiaravalloti
Journal:  Mult Scler Relat Disord       Date:  2016-03-24       Impact factor: 4.339

5.  Nocturnal sleep enhances working memory training in Parkinson's disease but not Lewy body dementia.

Authors:  Michael K Scullin; Lynn Marie Trotti; Anthony G Wilson; Sophia A Greer; Donald L Bliwise
Journal:  Brain       Date:  2012-08-20       Impact factor: 13.501

6.  A pilot study on the benefit of cognitive rehabilitation in Parkinson's disease.

Authors:  Natalia Adamski; Matthias Adler; Klaus Opwis; Iris-Katharina Penner
Journal:  Ther Adv Neurol Disord       Date:  2016-02-16       Impact factor: 6.570

7.  Processing speed versus working memory: contributions to an information-processing task in multiple sclerosis.

Authors:  Helen M Genova; Jeannie Lengenfelder; Nancy D Chiaravalloti; Nancy B Moore; John DeLuca
Journal:  Appl Neuropsychol Adult       Date:  2012       Impact factor: 2.248

Review 8.  Treatment of cognitive impairment in multiple sclerosis: position paper.

Authors:  Maria Pia Amato; Dawn Langdon; Xavier Montalban; Ralph H B Benedict; John DeLuca; Lauren B Krupp; Alan J Thompson; Giancarlo Comi
Journal:  J Neurol       Date:  2012-11-23       Impact factor: 4.849

Review 9.  Fatigue as a symptom or comorbidity of neurological diseases.

Authors:  Iris-Katharina Penner; Friedemann Paul
Journal:  Nat Rev Neurol       Date:  2017-10-13       Impact factor: 42.937

Review 10.  Treatment and management of cognitive dysfunction in patients with multiple sclerosis.

Authors:  John DeLuca; Nancy D Chiaravalloti; Brian M Sandroff
Journal:  Nat Rev Neurol       Date:  2020-05-05       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.